✦ LIBER ✦

Clinical observations on enzyme replacement therapy in patients with Fabry disease and the switch from agalsidase beta to agalsidase alfa

✍ Scribed by Lin, Hsiang-Yu; Huang, Yu-Hsiu; Liao, Hsuan-Chieh; Liu, Hao-Chuan; Hsu, Ting-Rong; Shen, Chia-I; Li, Shao-Tzu; Li, Cheng-Fang; Lee, Li-Hong; Lee, Pi-Chang; Huang, Chun-Kai; Chiang, Chuan-Chi; Lin, Shuan-Pei; Niu, Dau-Ming

Book ID: 122302288
Publisher: Elsevier Science
Year: 2014
Tongue: Chinese
Weight: 414 KB
Volume: 77
Category: Article
ISSN: 1726-4901
DOI: 10.1016/j.jcma.2013.11.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Prospective Results of Switching Enzyme

Prospective Results of Switching Enzyme Replacement Therapy from Agalsidase beta to Agalsidase alfa in the Canadian Fabry Disease Initiative Study

✍ Michael West; Daniel Bichet; Robin Casey; Joe Clarke; Sandra Sirrs; Gordon Flowe 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

An open-label, switchover trial to asses

An open-label, switchover trial to assess the safety and efficacy of agalsidase beta in patients with Fabry disease treated with agalsidase alfa enzyme replacement therapy

✍ Richards, Sarah; Laney, Dawn; Pervaiz, Muhammad A.; Shankar, Suma 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Evaluation of glycosphingolipid clearanc

Evaluation of glycosphingolipid clearance in patients with Fabry disease treated with agalsidase alfa who switched to agalsidase beta (the INFORM study)

✍ Barranger, John A.; Gambello, Michael J.; Goker-Alpan, Ozlem; Maegawa, Gustavo H 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Enzyme replacement therapy in a patient

Enzyme replacement therapy in a patient with Fabry disease and the development of IgE antibodies against agalsidase beta but not agalsidase alpha

✍ Tanaka, Akemi; Takeda, Taisuke; Hoshina, Takao; Fukai, Kazuyoshi; Yamano, Tsunek 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 281 KB

Evaluation of Plasma Globotriaosylsphing

Evaluation of Plasma Globotriaosylsphingosine in Patients with Anderson-Fabry Disease in Brazil on Enzyme Replacement Therapy with Agalsidase Alfa

✍ Charles Lourenco; Janice Coelho; Miguel Moyses Neto; Osvaldo Merege Vieira Neto; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 55 KB

Effects of enzyme replacement therapy wi

Effects of enzyme replacement therapy with agalsidase alfa on glomerular filtration rate in patients with Fabry disease: preliminary data

✍ F Dehout; A Schwarting; M Beck; A Mehta; R Ricci; U Widmer; on behalf of the FOS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB